Transmembrane Protein 173 (TMEM173) Peptide
TMEM173
适用: 哺乳动物
宿主: 合成
BP, WB, IHC
产品编号 ABIN937495
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for Transmembrane Protein 173 (TMEM173) Peptide (ABIN937495)
抗原
STING/TMEM173 (TMEM173)
(Transmembrane Protein 173 (TMEM173))
宿主
哺乳动物
资源
合成
应用范围
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
蛋白类型
- Synthetic
-
序列
- DPNIRFLDKL PQQTGDHAGI KDRVYSNSIY ELLENGQRAG TCVLEYATPL
-
产品特性
-
A synthetic peptide for use as a blocking control in assays to test for specificity of TMEM173 antibody,
Alternative Names: TMEM173 control peptide, TMEM173 antibody Blocking Peptide, Anti-TMEM173 Blocking Peptide, Transmembrane Protein 173 Blocking Peptide, FLJ38577 Blocking Peptide, TMEM173, TMEM-173, TMEM 173, TMEM-173 Blocking Peptide, TMEM 173 Blocking Peptide
-
-
-
-
应用备注
- Optimal conditions should be determined by the investigator
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
缓冲液
- PBS
-
注意事项
- Avoid repeated freeze/thaw cycles.
-
储存条件
- -20 °C
-
储存方法
- Store at -20 °C long term.
-
-
- STING/TMEM173 (TMEM173) (Transmembrane Protein 173 (TMEM173))
-
背景
- TMEM173 acts as a facilitator of innate immune signaling. It is able to activate both NF-kappa-B and IRF3 transcription pathways to induce expression of type I interferon (IFN-alpha and IFN-beta) and exert a potent anti-viral state following expression. TMEM173 may be involved in translocon function, the translocon possibly being able to influence the induction of type I interferons.It also may be involved in transduction of apoptotic signals via its association with the major histocompatibility complex class II (MHC-II). TMEM173 mediates death signaling via activation of the extracellular signal-regulated kinase (ERK) pathway.
-
分子量
- 42 kDa
抗原
-
You are here:
